About FDA
Percent of CDRH advisory committee member positions vacant at the end of the month
Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm
Information is current as of December 31, 2012.
Fiscal Year - 2011
| Time | Target | Percent Vacant Positions |
|---|---|---|
| Oct 2010 | 10 | 28 |
| Nov 2010 | 10 | 22 |
| Dec 2010 | 10 | 19 |
| Jan 2011 | 10 | 18 |
| Feb 2011 | 10 | 16 |
| Mar 2011 | 10 | 18 |
| Apr 2011 | 10 | 17 |
| May 2011 | 10 | 15 |
| Jun 2011 | 10 | 13 |
| Jul 2011 | 10 | 16 |
| Aug 2011 | 10 | 12 |
| Sep 2011 | 10 | 12 |
Number of CDRH advisory committee member positions vacant at the end of the month
Fiscal Year - 2011
| Time | Target | Vacant Positions |
|---|---|---|
| Oct 2010 | N/A | 56 |
| Nov 2010 | N/A | 44 |
| Dec 2010 | N/A | 38 |
| Jan 2011 | N/A | 36 |
| Feb 2011 | N/A | 33 |
| Mar 2011 | N/A | 36 |
| Apr 2011 | N/A | 35 |
| May 2011 | N/A | 30 |
| Jun 2011 | N/A | 26 |
| Jul 2011 | N/A | 32 |
| Aug 2011 | N/A | 24 |
| Sep 2011 | N/A | 24 |
Total number of CDRH advisory committee member positions at the end of the month
Fiscal Year - 2011
| Time | Target | Positions |
|---|---|---|
| Oct 2010 | N/A | 202 |
| Nov 2010 | N/A | 202 |
| Dec 2010 | N/A | 202 |
| Jan 2011 | N/A | 202 |
| Feb 2011 | N/A | 202 |
| Mar 2011 | N/A | 202 |
| Apr 2011 | N/A | 202 |
| May 2011 | N/A | 202 |
| Jun 2011 | N/A | 202 |
| Jul 2011 | N/A | 202 |
| Aug 2011 | N/A | 202 |
| Sep 2011 | N/A | 202 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
